Tacrolimus and Rhabdomyosarcoma - a phase IV clinical study of FDA data

Summary:

Rhabdomyosarcoma is reported as a side effect among people who take Tacrolimus (tacrolimus), especially for people who are female, 10-19 old, also take Prednisone, and have Glomerulonephritis membranoproliferative.

The phase IV clinical study analyzes which people have Rhabdomyosarcoma when taking Tacrolimus. It is created by eHealthMe based on reports of 115,828 people who have side effects when taking Tacrolimus from the FDA, and is updated regularly.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

What is Rhabdomyosarcoma?

Rhabdomyosarcoma (cancer of the bone, soft tissues, or connective tissue (e.g., tendon or cartilage)) is found to be associated with 69 drugs and 309 conditions by eHealthMe. Check the latest studies of Rhabdomyosarcoma.

On Jul, 06, 2026

115,828 people reported to have side effects when taking Tacrolimus.
Among them, 18 people (0.02%) have Rhabdomyosarcoma.

Could Tacrolimus cause Rhabdomyosarcoma?

Among these 18 people:

What is the gender of people who have Rhabdomyosarcoma when taking Tacrolimus? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Rhabdomyosarcoma when taking Tacrolimus? *

What are other drugs people take besides Tacrolimus? *

Prednisone: 11 people, 61.11%
Mycophenolate Mofetil: 10 people, 55.56%
Everolimus: 10 people, 55.56%
Sirolimus: 4 people, 22.22%
Decitabine: 3 people, 16.67%
Revlimid: 1 person, 5.56%
Hydrocortisone: 1 person, 5.56%
Etoposide: 1 person, 5.56%
Cytarabine: 1 person, 5.56%

What are other side effects people have besides Rhabdomyosarcoma? *

Epstein-Barr Virus Infection: 12 people, 66.67%
Gastrointestinal Toxicity (damage to digestive tract by any substance): 4 people, 22.22%
Ards (Acute Respiratory Distress Syndrome) (sudden failure of the respiratory (breathing) system): 3 people, 16.67%
Pneumonia: 3 people, 16.67%
Leukopenia (less number of white blood cells in blood): 3 people, 16.67%
Viraemia (presence of a virus in the blood stream): 2 people, 11.11%
Cardiac Arrest: 2 people, 11.11%
Drug Resistance (reduction in effectiveness of a drug): 2 people, 11.11%
Excessive Or Unwanted Hair In Women: 2 people, 11.11%
Unilateral Hydronephrosis (kidney stone that causes obstruction of the ureter): 2 people, 11.11%

What are the existing conditions these people have? *

Glomerulonephritis Membranoproliferative (a type of glomerulonephritis caused by deposits in the kidney glomerular mesangium and basement membrane (gbm) thickening): 9 people, 50.00%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 11.11%
Immunodeficiency Disorders: 2 people, 11.11%
Chloroma (green-coloured tumour): 2 people, 11.11%
Refractory Cancer (cancer that has not responded to treatment): 1 person, 5.56%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.56%
Epstein-Barr Virus Infection: 1 person, 5.56%
Epstein-Barr Virus Associated Lymphoma (epstein-barr virus associated tumour): 1 person, 5.56%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Tacrolimus and have Rhabdomyosarcoma?

- Check whether Rhabdomyosarcoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tacrolimus:

Tacrolimus (116,160 reports)

Browse all side effects of Tacrolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rhabdomyosarcoma:

Rhabdomyosarcoma (69 drugs)

Browse all the conditions that are associated with Rhabdomyosarcoma:

Rhabdomyosarcoma (309 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus (the active ingredients of Tacrolimus) and Tacrolimus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.